Concerns are mounting that ChatGPT may contribute to delusional thinking in vulnerable users. Families have filed lawsuits alleging AI-induced mental health crises, prompting a broader debate over the responsibilities of AI developers.

In a surprising turn at a major San Francisco AI event, Perplexity faced sharp criticism and was labeled “Most Likely to Fail.” Attendees expressed concerns about its sustainability and the broader implications for the competitive AI industry.

The U.S. Food and Drug Administration has requested additional information from Telix Pharmaceuticals regarding its experimental diagnostic tool for a form of kidney cancer. This development underscores the regulatory rigor that emerging medical products must meet before approval.

Federal regulators are examining whether Tesla accurately and promptly reported crashes involving its Autopilot and Full Self-Driving features. While the company says a systems error caused delayed notifications, the NHTSA is investigating to ensure all required reports have been submitted.

Tesla’s recent launch of its robotaxi service in Austin has sent stock prices soaring, even as incidents caught on camera draw regulatory attention. Elon Musk is betting big on autonomous cabs to revitalize the company amid previous sales slumps.